Septo-subicular cholinergic circuit promotes seizure development via astrocytic inflammation
Yu Wang1, Qingyang Zhang1, Fan Fei1
1Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310053, China.
None:
The central dogma explaining epileptic seizures largely revolves around the classic theory of "excitability-inhibition" imbalance between glutamatergic and GABAergic transmission. Cholinergic neurons play a significant role in epilepsy; however, these neuronal populations are molecularly and structurally heterogeneous. Here, we show a subpopulation of subiculum-projecting septal cholinergic neurons that promote seizure development. Functionally, this subpopulation is suppressed during seizures. Selective manipulation of the septo-subicular cholinergic circuit bidirectionally regulates the development of hippocampal seizures. Notably, cholinergic signaling enhances subicular astrocytic caspase-1-mediated neuroinflammation via M3 muscarinic receptors, increasing excitatory synaptic transmission and promoting seizure development. Together, these results demonstrate that activation of the septo-subicular cholinergic circuits facilitates seizure development via astrocytic inflammation. Our findings provide insight into the cholinergic mechanism involved in epilepsy and suggest targeted therapeutic strategies for epilepsy treatment, focusing on the specific cholinergic neuronal subpopulation.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Encephalitis ll: Pathophysiology
Seizures l: Introduction


